Twist Bioscience
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $99,009 | $96,057 | $92,793 | $88,713 |
Gross Profit | 50,837 | 51,297 | 46,028 | 42,840 |
EBITDA | -26,339 | 26,381 | -32,606 | -25,093 |
EBIT | 20,581 | -39,010 | -31,473 | |
Net Income | -26,978 | 20,390 | -39,328 | -31,594 |
Net Change In Cash | 99,009 | 96,057 | 92,793 | 88,713 |
Free Cash Flow | -24,241 | -10,565 | -17,130 | -23,696 |
Cash | 183,049 | 201,373 | 210,437 | 221,403 |
Basic Shares | 60,424 | 61,164 | 59,649 | 59,162 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $376,572 | $312,974 | $245,109 | $203,565 |
Gross Profit | 191,002 | 133,349 | 89,729 | 84,235 |
EBITDA | -52,098 | -176,705 | -174,151 | -247,046 |
EBIT | -76,951 | -208,137 | -203,461 | -249,021 |
Net Income | -77,670 | -208,726 | -204,618 | -217,863 |
Net Change In Cash | 376,572 | 312,974 | 245,109 | 203,565 |
Cost of Revenue | -86,781 | |||
Free Cash Flow | -75,632 | -69,170 | -170,253 | -226,242 |
Cash | 183,049 | 226,316 | 286,470 | 378,687 |
Basic Shares | 59,808 | 58,016 | 56,885 | 53,885 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.45 |
2025-06-30 | -$0.47 |
2025-03-31 | -$0.66 |
2024-12-31 | -$0.53 |
